Moran Wealth Management LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH – Free Report) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 1,362 shares of the company’s stock, valued at approximately $229,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Sequoia Financial Advisors LLC lifted its stake in shares of Cardinal Health by 11.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 8,946 shares of the company’s stock worth $1,503,000 after acquiring an additional 916 shares during the last quarter. Bill Few Associates Inc. purchased a new stake in Cardinal Health in the second quarter worth $216,000. Yarger Wealth Strategies LLC increased its stake in Cardinal Health by 4.3% in the second quarter. Yarger Wealth Strategies LLC now owns 1,835 shares of the company’s stock worth $308,000 after purchasing an additional 76 shares during the period. LRI Investments LLC increased its stake in Cardinal Health by 44.9% in the second quarter. LRI Investments LLC now owns 1,230 shares of the company’s stock worth $207,000 after purchasing an additional 381 shares during the period. Finally, Alta Advisers Ltd purchased a new stake in Cardinal Health in the second quarter worth $201,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Cardinal Health
In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by corporate insiders.
Cardinal Health Stock Up 2.0%
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the business posted $1.84 EPS. The business’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.
Wall Street Analysts Forecast Growth
Several research firms recently commented on CAH. Evercore ISI reduced their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $166.00.
Check Out Our Latest Stock Report on Cardinal Health
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- Are Penny Stocks a Good Fit for Your Portfolio?
- This AI Chip Giant Could Be the Market’s Next Big Winner
- How to trade penny stocks: A step-by-step guide
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Short Selling – The Pros and Cons
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.